Intrinsiqs

Is Viatris Inc. overvalued?

Viatris Inc. (VTRS) looks undervalued — trading about 229% below its fair value.

Undervalued
Current price $20.82 Fair value $68.45
Price
$20.82
Fair value
$68.45
Current P/E
8.5
Normal P/E
27.9
Market cap
$23.87B
Dividend yield
2.3%
Return on equity
-4.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares VTRS's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.